Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-blockers and glucose control.

G A Mills, J R Horn

    Drug Intelligence & Clinical Pharmacy
    |April 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Beta-blockers affect blood glucose regulation by influencing adrenergic pathways. While generally safe for non-diabetics, they pose risks for diabetics, potentially altering hypoglycemia symptoms and worsening hyperglycemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Left colectomy for diverticular disease: systematic review and meta-analysis comparing robotic and laparoscopic resections.

    Techniques in coloproctology·2025
    Same author

    Riggs's Disease-What Is It, and Can It Be Cured?

    International dental journal (Philadelphia, Pa.)·2023
    Same author

    How Can We Magnify the Importance of Our Calling?

    International dental journal (Philadelphia, Pa.)·2023
    Same author

    What Can We Demonstrate?

    International dental journal (Philadelphia, Pa.)·2023
    Same author

    Resistibility.

    International dental journal (Philadelphia, Pa.)·2023
    Same author

    New Field Suggested by Dr. Williams's Paper.

    International dental journal (Philadelphia, Pa.)·2023
    Same journal

    Profile of prescription medication in a pediatric population.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    SI units in drug therapeutics.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Physicians' review of significant interventions by clinical pharmacists in inpatient care.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Possible interaction of ranitidine with phenytoin.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Famotidine-associated mental confusion in elderly patients.

    Drug intelligence & clinical pharmacy·1988
    Same journal

    Intravenous self-administration of elemental mercury: efficacy of dimercaprol therapy.

    Drug intelligence & clinical pharmacy·1988
    See all related articles

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Metabolic Regulation

    Background:

    • Adrenergic signaling plays a crucial role in glucose homeostasis.
    • Beta-adrenergic stimulation influences insulin, glucagon, glycogenolysis, gluconeogenesis, and lipolysis.
    • Alpha-adrenergic stimulation has opposing effects on insulin and glucagon secretion.

    Purpose of the Study:

    • To review the literature on beta-blocker effects on blood glucose.
    • To examine adrenergic influences on glucose regulation.
    • To assess beta-blockade effects during hypo- and hyperglycemia in various populations.

    Main Methods:

    • Comprehensive literature review.
    • Analysis of data on adrenergic mechanisms in glucose metabolism.
    • Evaluation of clinical effects of beta-blockers in normal and diabetic individuals.

    Related Experiment Videos

    Main Results:

    • Beta-blockers pose minimal risk to glucose control in non-diabetic individuals.
    • In insulin-dependent diabetics, beta-blockers can alter hypoglycemia symptoms.
    • Hyperglycemia is a significant risk in non-insulin-dependent diabetics using beta-blockers.

    Conclusions:

    • Beta-blockers can increase blood glucose concentrations.
    • The action of oral hypoglycemic drugs may be antagonized by beta-blockers.
    • Careful consideration of beta-blocker use is warranted in diabetic patients.